ArticlePloS one2017

Anti-citrullinated peptide antibodies are the strongest predictor of clinically relevant radiographic progression in rheumatoid arthritis patients achieving remission or low disease activity: A post hoc analysis of a nationwide cohort in Japan.

Tomohiro Koga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.